BONEBRIDGE Bone Conduction Implant in Adults
common.study.values.description
“BONEBRIDGE Bone Conduction Implant in Adults”
Approximately thirty subjects with mixed or conductive hearing loss, meeting FDAa??cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months posta??activation to assess safety and effectiveness of the BONEBRIDGE implant.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Device - BONEBRIDGE
Bone Conduction Implant
participant.views.study.view.additional
participant.views.study.view.scientific-title
Outcomes in Adults With Mixed or Conductive Hearing Loss Implanted With the BONEBRIDGE
common.study.values.clinical-trial-id
NCT03859648
participant.views.study.view.id
eZ6G2e